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Profiling polyphenol composition by
HPLC-DAD-ESI/MSn and the antibacterial activity
of infusion preparations obtained from four
medicinal plants†
Borhane E. C. Ziani,a,b,c Lillian Barros, *a Ali Z. Boumehira,b Khaldoun Bachari,b
Sandrina A. Heleno, a Maria Jose Alves a and Isabel C. F. R. Ferreira *a
The infusions of Thymus pallescens Noë, Saccocalyx satureioides Coss. et Dur., Ptychotis verticillata Briq.
and Limoniastrum guyonianum Boiss. have been used as medicinal remedies for many diseases in Algerian
folk medicine. These species have also been well documented as rich sources of phytochemicals, such as
phenolic compounds with wide diversified chemical structures, which exhibit far-ranging biological activi-
ties. Thus, the phenolic compound profile of the aqueous extracts, obtained by infusing, of the mentioned
species was obtained by HPLC-DAD-ESI/MS, and their antibacterial activity was evaluated against clinical
isolates. Several phenolic acids were identified and quantified, particularly caffeic acid derivatives along with
glycosylated flavonoids. T. pallescens and S. satureioides contain 13 phenolic compounds, where rosmarinic
acid was the most abundant phenolic acid present, while L. guyonianum presented myricetin-3-O-gluco-
side and myricetin-O-rhamnoside as the main compounds among the eight detected molecules.
P. verticillata presented a profile of ten phenolic compounds, where 5-O-caffeoylquinic acid was the most
abundant phenolic acid, followed by the flavone luteolin-3-O-glucoside. The antibacterial activity of the
infusions ranged between 2.5 and 20 mg mL−1 (MIC values), and L. guyonianum showed the highest activity
against all of the tested bacteria, Staphylococcus aureus and Pseudomonas aeruginosa being the most
sensitive and resistant strains, respectively. Thus, the studied plant species are sources of natural antibacterial
substances that can be used to fight against pathogenic microorganisms.
1 Introduction
Phenolic compounds are generally part of a complex mixture
isolated from plants and other matrices of biological origin.1,2
They are interesting candidates for the discovery of new anti-
microbial agents to be loaded into or coated onto biomater-
ials.3,4 Consequently, it is essential to identify and measure all
of the bioactive constituents of medicinal plants in order to
ensure the reliability and repeatability of biological research as
well as to enhance the quality control over the pharmacological
benefits and/or hazards.5,6 Liquid chromatography coupled with
different detectors, such as a diode array detector (DAD) and a
mass spectrometer (MS), plays a prominent role as an analytical
tool for detecting and identifying active and/or reactive meta-
bolites.7,8 MS detection not only allows one to determine natural
compounds’ chemical structures, but also offers excellent sensi-
tivity with sufficient precision and selectivity within a reasonable
time, playing an important role in the analysis of phenolic com-
pounds (e.g. flavonoids, phenolic acids and others).7,9–11
Antibiotic resistance is a serious and growing phenomenon
in contemporary medicine and has emerged as one of the pre-
eminent public health concerns in the 21st century.4,12 Most
pathogenic bacteria have developed resistance to modern anti-
biotics, as a result of which we are observing multi-drug resis-
tance among bacterial strains.4,13 Herbal medicine has been
assumed to be an effective alternative to resolve this problem
due to the bioactivities of herbs and many studies have been
conducted across the globe to prove the antimicrobial
efficiency and/or properties of several plants.3,14,15
Algerian medicinal plants contain a great number of bioactive
compounds with therapeutic effects,16–18 and have been used
since ancient times as herbal remedies.19,20 However, the phyto-
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chemical constituents of many of these species are still
unknown.16,21 Thymus pallescens Noë, Saccocalyx satureioides
Coss. et Dur., Ptychotis verticillata Briq and Limoniastrum guyonia-
num Boiss. are some examples of unexplored medicinal plants
from Algeria. T. pallescens (Lamiaceae family) is an endemic
plant to the northern region of Algeria, widely used for its anti-
tussive, antiseptic, expectorant, anti-helmintic and antispasmo-
dic properties.22 While, S. satureioides, also from the Lamiaceae
family, is an aromatic shrub (20–100 cm). This endemic plant
is normally grown in septentrional Sahara, Algeria.23,24 In folk
medicine, the aerial parts are commonly used in water prepara-
tions (infusions and decoctions) for the treatments of gastric
disorders and spasms,25 as well as for diabetes.26 The anti-
microbial properties of its essential oils have been previously
studied,25,27,28 nonetheless, the polar extracts have been less
explored. Ptychotis verticillata Briq (Apiaceae family), also known
as Ammoides verticillata Briq or Ptychotis ammoides Koch. and
commonly named Nûnkha,29,30 is an aromatic herbaceous
species (10–35 cm tall), endemic to northwestern Algeria and
used for its culinary and medicinal properties as a febrifuge,
antispasmodic, antiseptic and antidiabetic, especially in decoc-
tions and infusions.31,32 Moreover, the infusions and ethanolic
extracts have been reported to have a wide diversity of poly-
phenols (flavonoids, saponins, and tannins), while its essential
oils are mainly characterized by the presence of thymol and car-
vacrol.33 L. guyonianum (Plumbaginaceae family) is a medicinal
halophyte species endemic to the north of Africa; the infusion of
its leaves and galls are traditionally used as an anti-dysenteric
against infectious diseases or parasites responsible for painful
and bloody diarrhea.34 Recent studies performed by Ziani et al.16
and Krifa et al.35 demonstrated the antioxidant and antitumor
potential of this plant.
To the best of the authors’ knowledge, the phytochemical
analysis of T. pallescens, S. satureioides and P. verticillata has
not been previously reported. The chemical characterization
and simultaneous analysis of the most prominent compounds
are therefore necessary to clearly understand the biological
properties of these plants. The infusion preparations of these
four medicinal plant species were chosen to continue a pre-
vious study of the authors,16 where their antioxidant and cyto-
toxic properties were reported and different hydrophilic bio-
active compounds were also quantified spectrophotometri-
cally. Therefore, the aim of the present work was to identify
those bioactive compounds by using HPLC-DAD-ESI/MSn.
Furthermore, the antibacterial activity of the infusions was
also tested against six Gram-negative and four Gram-positive
multi-resistant bacterial strains.
2 Materials and methods
2.1. Plant material
The aerial parts of the four species (Thymus pallescens Noë,
Saccocalyx satureioides Coss. et Dur., Limoniastrum guyonianum
Boiss. and Ptychotis verticillata Briq) were harvested from some
semi-arid and arid areas in Algeria between April and May
2014 as described in a previous study,16 taking into account
local consumers’ criteria for the seasoning use of these species
and the optimal growth stage and gathering period. A voucher
specimen of each species was deposited in the herbarium of
the Department of Botany of the National Superior School of
Agronomy (ENSA), where the taxonomic criteria of the
authors30,36 were used for botanical identification. After
40 days of shade-drying in the dark, all of the samples were
ground for all of the subsequent analyses.
For the infusion preparation, 1 g of the plant material was
added to 200 mL of boiling distilled water and left to infuse at
room temperature for 5 min, and then filtered through
Whatman paper. The obtained infusions were frozen at −20 °C
and lyophilized for further analyses.
2.2. Standards and reagents
Acetonitrile and methanol HPLC-grade and formic acids were
purchased from Fisher Scientific (Lisbon, Portugal). Phenolic
compound standards were obtained from Extrasynthese
(Genay, France) and their purities were above 97%, as deter-
mined by HPLC-DAD analysis and stock solutions of these
compounds (1 mg mL−1) were prepared in methanol/water
(20 : 80, v/v). The culture media Mueller–Hinton broth (MHB)
and tryptic soy broth (TSB) as well as blood agar with 7%
sheep blood and MacConkey agar plates were obtained from
Biomerieux (Marcyl’Etoile, France). The dye p-iodonitrotetra-
zolium chloride (INT) was purchased from Sigma-Aldrich
(St Louis, MO, USA) and was used as a microbial growth indi-
cator. Water was treated using the Milli-Q water purification
system (TGI Pure WaterSystems, Greenville, SC, USA).
2.3. Phenolic compound characterization by HPLC-DAD-ESI/
MSn
For the LC/MS analysis, lyophilized infusion extracts were dis-
solved in water at a concentration of 10 mg mL−1 and filtered
through a 0.22 μm disposable LC filter disk prior to the ana-
lysis. Spectral UV-Vis data from all peaks were collected in the
range of 240–600 nm, and chromatograms were recorded at
370, 330 and 280 nm for phenolic compound analysis. The
HPLC-DAD-ESI/MSn (Dionex Ultimate 3000 UPLC) consisted of
a diode array detector (DAD) connected to a Linear Ion Trap
LTQ XL mass spectrometer (Thermo Scientific, San Jose, CA,
USA), following a procedure previously reported by the
authors.37 Chromatographic separation was performed using a
Waters Spherisorb S3ODS-2 C18 automated column (3 µm,
4.6 × 150 mm, Waters, Milford, MA, USA) and the mass detec-
tion was performed using ESI, operating in negative mode.
An Xcalibur®data system (ThermoFinnigan, San Jose, CA, USA)
was used for data acquisition.
Phenolic compound identification was achieved by compar-
ing retention times and UV–vis and mass spectra with those of
available standard compounds. Otherwise, the available data
reported in the literature were applied to identify the com-
pounds. The quantification of these compounds was calcu-
lated from the calibration curves (2.5–100 µg mL−1) of each
available phenolic standard or by using the most similar stan-
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dard available. The results were expressed as mean values ±
standard deviations (SD), in mg g−1 of lyophilized infusion
extract.
2.4. Evaluation of the antibacterial activity
2.4.1. Microorganisms and culture conditions. The tested
bacterial strains were clinical isolates obtained from patients
hospitalized in the Local Health Unit of Bragança and Hospital
Centre of Trás-os-Montes and Alto-Douro, Vila Real, northeast
of Portugal. Six Gram-negative bacteria: Morganella morganii
and Pseudomonas aeruginosa isolated from expectoration,
Escherichia coli, extended spectrum beta-lactamase (ESBL)-
producing E. coli, Klebsiella pneumoniae and extended-spectrum
beta-lactamase (ESBL)-producing K. pneumoniae isolated from
urine; and four Gram-positive bacteria: Enterococcus faecalis iso-
lated from urine, Listeria monocytogenes isolated from cerebro-
spinal fluid, methicillin-sensitive Staphylococcus aureus (MSSA)
isolated from wound exudate, and methicillin-resistant
Staphylococcus aureus (MRSA) isolated from expectoration were
tested. All strains were identified and characterized regarding
the antibiotic susceptibility using the MicroScan® panels auto-
mated methodology (Siemens, Medical Solutions Diagnostics
Camberley, West Sacramento, CA, USA). The interpretation
criteria were based on interpretive breakpoints as indicated in
Clinical and Laboratory Standards Institute,38 and in the
European Committee on Antimicrobial Susceptibility Testing.39
Table S1 (ESI†) shows the sensitivity/resistance profiles of the
different antibiotics tested for each clinical isolate.
2.4.2. Determination of the minimal inhibitory concen-
trations (MICs). A microdilution method and the rapid p-iodo-
nitrotetrazolium chloride (INT) colorimetric assay were used to
determine the minimum inhibitory concentration (MIC).40
Briefly, stock solutions of 100 mg mL−1 were prepared and
100 µL of each stock solution (100 mg mL−1) was diluted in
400 µL of MHB or TSB media according to bacteria require-
ments (making a solution of 20 mg mL−1). Then, 200 µL of
this extract solution was then added to the first well of a micro-
plate (96-well microplate) and 100 µL from the first well were
pipetted to other wells containing 100 µL of media making
successive dilutions.
Afterwards, 10 µL of inoculum (1.5 × 108 CFU mL−1) of
fresh overnight cultures of bacteria was added to all of the
wells containing the test concentrations in the range of 20 to
0.156 mg mL−1. Three negative controls were prepared (one
with MHB/TSB, another one with the extract, and the third one
with the medium, inoculum and antibiotic).
The MIC of the samples was determined after adding INT
(0.2 mg mL−1, 40 µL) and after incubation at 37 °C in an oven
(Jouan, Berlin, Germany) for 30 min where the viable micro-
organisms reduced the yellow dye to pink. The MIC was defined
as the lowest extract concentration that prevented this change
and exhibited the complete inhibition of bacterial growth.
2.5. Statistical analysis
Three repetitions of each sample and triplicates of the infu-
sion preparations were used in each assay. In order to deter-
mine the significant difference among samples, a Student’s
t-test (with p = 0.05, significant differences between samples)
was applied (IBM SPSS Statistics for Windows, version 23.0,
IBM Corp., Armonk, New York, USA).
3 Results and discussion
3.1. HPLC-DAD-ESI/MSn analysis of phenolic compounds
The HPLC-DAD-ESI/MSn chromatographic profiles of the
studied plants are shown in Fig. 1 and 2. Tables 1–3 list all of
the characterized metabolites obtained by the chromato-
graphic analysis.
Regarding the phenolic composition of Thymus pallescens
and Saccocalyx satureioides, as both species belong to the
Lamiaceae family, the profiles were very similar to other
species belonging to this family.41–43 Thirteen compounds (six
phenolic acid derivatives and seven flavonoids) were identified
in both species, based on their chromatographic behavior and
mass spectra, in comparison with the literature. Table 1 sum-
marizes the identified compounds, their retention times and
m/z values for the parent ion and fragment ions. Both samples
presented flavonol derivatives (quercetin, kaempferol glycoside
derivatives), flavone derivatives (apigenin and luteolin glyco-
side derivatives) and phenolic acid derivatives, mainly caffeic
acid derivatives, such as caffeic acid dimers, trimers, and tetra-
mers (dimers of rosmarinic acid). To the best of the authors’
knowledge, this is the first report regarding the phenolic com-
position of these two species.
Compounds 1, 5, 7, 8 and 12 were identified as 5-O-caffeoyl-
quinic acid, quercetin-3-O-glucoside, luteolin-7-O-rutinoside,
luteolin-7-O-glucuronide and rosmarinic acid, respectively,
according to their DAD spectra, mass characteristics and reten-
tion times when compared with commercial standards. With
the exception of compounds 1 and 5, which were only present
in T. pallescens and compound 4 that was only present in
S. satureioides, the other compounds were found in both
samples.
Compounds 4, 9, 11, 13, 15 and 16 were identified as
caffeic acid derivatives. Compound 4 ([M − H]− at m/z 521)
fragmented at m/z 359 (rosmarinic acid, loss of −162 mu, hexo-
side moiety), which allowed its identification as rosmarinic
acid hexoside. Compound 9 ([M − H]− at m/z 719) released a
main MS2 fragment at m/z 359 ([M − 2H]2−, rosmarinic acid),
allowing its identification as sagerinic acid.44 Compounds 15
and 16 ([M − H]− at m/z 537) revealed a similar UV spectrum
and fragmentation pattern, being identified as a caffeic acid
trimer, lithospermic acid A, taking into account literature
findings.44–47 Compound 11 ([M − H]− at m/z 555) was tenta-
tively assigned to salvianolic acid K, due to a similar fragmen-
tation pattern described by Hauck et al.48
The remaining molecules (peaks 2, 3, 6, 10, 13 and 14)
correspond to flavonoid derivatives. Compound 2 ([M − H]− at
m/z 593) released the MS2 fragment ions at m/z 473 and 383
(loss of 120 and 90 mu characteristic of C-hexosyl flavones)
and at m/z 353 corresponding to apigenin aglycone (apigenin +
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83 mu, bearing some sugar residues),49 which allowed the
identification of this compound as apigenin-C-hexoside
C-hexoside. Thus, this compound was tentatively identified as
apigenin-6,8-C-diglucoside. Compounds 3 and 6 presented a
UV spectrum characteristic of luteolin (λmax at 350 nm) and
the same pseudomolecular ion [M − H]− at m/z 637, releasing
two fragments at m/z 461 and 285 ([M − 176 − 176]−, loss of
two glucuronyl moieties), being identified as luteolin-O-diglu-
curonide. Similar findings were taken into account to identify
compounds 13 and 14, which were assigned to apigenin-
O-glucuronide and kaemferol-O-glucuronide, respectively.
Compound 3 was only detected in S. satureioides, while com-
pound 6 was identified in T. pallescens. Finally, compound 10
([M − H]− at m/z 549), releasing MS2 fragments at m/z 301
([M − H − 162 − 86]−, loss of a malonylhexoside moiety) was
assigned to quercetin-O-malonylhexoside, being only present
in S. satureioides. Rosmarinic acid was the most abundant
phenolic acid present in both samples, while luteolin-7-O-
glucuronide was the most abundant flavonoid present in
T. pallescens and apigenin-6,8-C-dihexoside was predominant
in S. satureioides.
In the case of L. guyonianum infusion, only flavonol glycoside
derivatives were detected, related to myricetin (λmax around
354 nm, an MS2 fragment at m/z 317). They presented MS2
fragments corresponding to distinct losses of glucuronyl
(−176 mu), glucosyl (−162 mu) and rhamnosyl (−146 mu) moi-
eties, and an elution order coherent with the type of substituent
sugar, according to their expected polarity, being assigned to
myricetin-O-glucuronide (peak 2Lg), myricetin-3-O-glucoside
(peak 3Lg, positively identified with the commercial standards),
and myricetin-O-rhamnoside (peak 5Lg), respectively. Myricetin
and its derivatives have been previously described in
Limoniastrum feei (Girard) Batt from Algeria50 as myricetin-3-O-
beta-galactopyranoside and myricetin-3-O-alpha-rhamnopyrano-
side. Taking into account the position and nature of the sugar
moieties, peaks 2Lg and 5Lg were assumed to be myricetin-3-O-
glucuronide and myricetin-3-O-rhamnoside, respectively.
Furthermore, compound 1Lg was identified as a hexosyl
derivative of myricetin that also appeared to be attached to a
gallic acid moiety (−152 mu), yielding a deprotonated ion at
m/z 631, which consisted of a myricetin-hexosyl-gallate.
Compounds 4Lg, 6Lg and 8Lg presented the same pseudomole-
cular ion [M − H]− at m/z 505, releasing an MS2 fragment at
m/z 317 (myricetin; [M − H − 42 − 162]−, loss of an acetylhexo-
side moiety), being assigned to myricetin-O-acetylhexoside.
No further identification was possible to obtain for peak 7Lg
Fig. 1 HPLC-DAD-ESI/MSn phenolic profile of Thymus pallescens (A) and Saccocalyx satureioides (B) infusions, recorded at 280 nm.
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Fig. 2 HPLC-DAD-ESI/MSn phenolic profile of Limoniastrum guyonianum (A) and Ptychotis verticillata (B) infusions, recorded at 370 nm.
Table 1 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identification and
















1 7.32 326 353 191(100), 179(5), 161(3), 135(3) 5-O-Caffeoylquinic acid 2.59 ± 0.04 nd —
2 10.13 327 593 473(3), 383(15), 353(2),
311(3), 297(36)
Apigenin-6,8-C-dihexoside 2.54 ± 0.01 12.2 ± 0.4 <0.001
3 12.57 336 637 461(100), 285(7) Luteolin-O-diglucuronide nd 5.0 ± 0.2 —
4 14.55 320 521 359(100), 197(4), 179(4),
161(3), 135(2)
Rosmarinic acid hexoside nd 1.68 ± 0.08 —
5 15.28 342 477 301(100) Quercetin-3-O-glucoside 2.17 ± 0.07 nd —
6 16.1 334 637 461(100), 285(20) Luteolin-O-diglucuronide 1.23 ± 0.01 nd —
7 17.94 343 593 285(100) Luteolin-7-O-rutinoside 1.30 ± 0.01 1.22 ± 0.01 <0.001
8 18.58 347 461 285(100) Luteolin-7-O-glucuronide 11.5 ± 0.3 5.2 ± 0.2 <0.001
9 19.53 283, 328 719 539(25), 521(20), 359(100),
297(3), 179(36), 161(2), 135(3)
Sagerinic acid 2.78 ± 0.07 2.39 ± 0.01 <0.001
10 20.5 334 549 505(30), 463(100), 301(20) Quercetin-O-malonyhexoside nd 1.11 ± 0.01 —
11 21.71 288, 323 555 537(5), 511(8), 493(10), 311(100),
197(19), 179(3), 161(3), 135(12)
Salvianolic acid K 5.72 ± 0.01 2.72 ± 0.02 <0.001
12 22.24 328 359 197(27), 179(37), 161(100), 135(2) Rosmarinic acid 43.1 ± 0.8 50.1 ± 0.4 <0.001
13 23.11 335 445 269(100) Apigenin-O-glucuronide 4.56 ± 0.05 3.3 ± 0.1 <0.001
14 24.74 340 461 285(100) Kaempferol-O-glucuronide 29.1 ± 0.5 1.35 ± 0.03 <0.001
15 25.54 329 537 493(8), 359(100), 313(11), 295(4),
197(2), 179(3), 161(2)
Lithospermic acid A isomer I 20.9 ± 0.9 21.69 ± 0.02 0.107
16 30.76 329 537 493(9), 359(100), 313(9), 295(3),
197(3), 179(3), 161(4)
Lithospermic acid A isomer II 2.7 ± 0.1 2.22 ± 0.03 <0.001
Total phenolic acid 78 ± 2 80.8 ± 0.5 0.020
Total flavonoids 52.4 ± 0.9 29.3 ± 0.9 <0.001
Total phenolic compounds 130 ± 3 110 ± 1 <0.001
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([M − H]− at m/z 659), being assigned to a myricetin derivative.
The major myricetin derivatives present in this sample were
myricetin-3-O-glucoside and myricetin-O-rhamnoside, respectively.
The phenolic profile of P. verticillata infusion, determined
by HPLC-DAD-ESI/MSn, presented three chlorogenic acids,
being compounds 1, 2 and 3 ([M − H]− at m/z 353) identified
as 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid and 5-O-
caffeoylquinic acid, respectively, according to their similar
fragmentation pattern previously described by Clifford
et al.51,52 The remaining compounds were identified as
flavonols (peaks 6Pv, 7Pv, 9Pv and 10Pv) and flavones (4Pv, 5Pv
and 8Pv). The latter compounds 4Pv (luteolin-3-O-rutinoside),
5Pv (luteolin-3-O-glucuronide) and 8Pv (apigenin-3-O-glucoside)
were positively identified with commercial standards. Peak 7Pv
([M − H]− at m/z 505) released two fragments, at m/z 463 (−42,
loss of a acetyl moiety) and m/z 301 (−162 u, loss of a hexosyl
moiety), thus being tentatively assigned to quercetin-O-acetyl-
hexoside. Compounds 6Pv ([M − H]− at m/z 609), 9Pv ([M − H]−
at m/z 447) and 10Pv ([M − H]− at m/z 489) were identified as
kaempferol glycosides based on their UV spectra (λmax around
348 nm) and the production of an MS2 fragment ion at m/z
285, and could be assumed as kaempferol-O-dihexoside,
kaempferol-O-glucuronide and kaempferol-O-acetylhexoside,
respectively. 5-O-Caffeoylquinic acid was the most abundant
compound, followed by the flavone luteolin-3-O-glucoside.
3.2. Antibacterial activity
The search for natural antimicrobial compounds in clinical
microbiology is incited by the need to thwart the increasing
infectious diseases caused by multiple drug resistant (MDR)
and total drug resistant (TDR) strains.4 In the biomedical
field, the microbial antibiotic-resistance leads to a growing
need for new, effective anti-infective materials for the preven-
tion and delay of implant and device-associated infections.53
In the present work, the antibacterial activity of the samples
was tested against ten bacteria, some of them being multiresis-
tant. The infusion of L. guyonianum showed the highest activity
against E. coli, E. coli ESBL, MRSA and MSSA (MICs = 2.5
mg mL−1), followed by K. pneumoniae, K. pneumoniae ESBL,
E. faecalis, L. monocytogenes (MICs = 5 mg mL−1), and
P. aeruginosa and M. morganii (MICs ranging between
10–20 mg mL−1). The infusions of T. pallescens and
S. satureioides showed almost similar values and were found to
be less active against K. pneumoniae, K. pneumoniae ESBL,
E. faecalis, L. monocytogenes, P. aeruginosa and M. morganii
strains (MICs ranging from 2.5 to >20 mg mL−1) (Table 4).
P. verticillata infusion showed the weakest activity against all of
the bacteria presenting MIC values in the highest tested con-
centration or even presenting no activity at the maximum
tested concentration: 20 mg mL−1. These results showed that
Table 2 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identification and
quantification of phenolic compounds in Limoniastrum guyonianum infusion
Peak Rt (min) λmax (nm) [M − H]− (m/z) MS2 (m/z) Tentative identification
Quantification
(mg g−1 extract)
1Lg 13.99 353 631 479(5), 317(100) Myricetin-hexosyl-gallate 5.73 ± 0.05
2Lg 14.61 353 493 317(100) Myricetin-3-O-glucuronide 6.90 ± 0.08
3Lg 15.21 356 479 317(100) Myricetin-3-O-glucoside 8.2 ± 0.2
4Lg 17.5 354 535 317(100) Myricetin-O-acetylglucoronide 5.41 ± 0.02
5Lg 17.83 349 463 317(100) Myricetin-3-O-rhamnoside 8.12 ± 0.05
6Lg 19.75 355 535 317(100) Myricetin-O-acetylglucoronide 5.36 ± 0.06
7Lg 20.72 352 659 493(12), 479(100), 317(51) Myricetin derivative 5.17 ± 0.03
8Lg 22.33 353 535 317(100) Myricetin-O-acetylglucoronide 5.36 ± 0.01
Total phenolic compounds 50.3 ± 0.5
Table 3 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identification and







(m/z) MS2 (m/z) Tentative identification
Quantification
(mg g−1 extract)
1Pv 4.94 323 353 191(100), 179(45), 161(3), 135(8) 3-O-Caffeoylquinic acid 3.04 ± 0.10
2Pv 6.77 325 353 191(11), 179(2), 173(100), 161(1), 135(4) 4-O-Caffeoylquinic acid 3.42 ± 0.15
3Pv 7.31 326 353 191(100), 179(2), 161(3), 135(4) 5-O-Caffeoylquinic acid 40.90 ± 1.32
4Pv 18.28 347 593 285(100) Luteolin-7-O-rutinoside 1.49 ± 0.03
5Pv 19.21 347 447 285(100) Luteolin-7-O-glucoside 5.99 ± 0.22
6Pv 19.93 347 609 285(100) Kaempferol-O-dihexoside 0.75 ± 0.03
7Pv 20.42 347 505 463(25), 301(100) Quercetin-O-acetylhexoside 1.20 ± 0.03
8Pv 23.46 332 431 269(100) Apigenin-7-O-glucoside 2.67 ± 0.03
9Pv 23.79 347 447 285(100) Kaempferol-O-glucuronide 5.44 ± 0.32
10Pv 24.2 337 489 285(100) Kaempferol-O-acetylhexoside 0.74 ± 0.01
Total phenolic acid 47.35 ± 1.57
Total flavonoids 18.28 ± 0.67
Total phenolic compounds 65.63 ± 2.25
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the plant infusions can inhibit bacterial strains irrespective of
their mechanisms of resistance. No significant differences
were observed between the strains showing well-known
mechanisms of resistance and the susceptible ones, because
one-dilution differences in this kind of analysis are taken for
granted.
Many research groups have gone one step further and iso-
lated and identified the structure of flavonoids that possess
antibacterial activity. The studied infusions were found to be
rich sources of phenolic components that could exert anti-
bacterial activity. For instance, flavonols and their derivatives,
as they were found abundantly in the infusion of T. pallescens
(quercetin and kaempferol) and L. guyonianum (myricetin), are
characterized by a remarkable antibacterial activity against
both Gram-positive and Gram-negative bacteria, such as
S. aureus, Lactobacillus acidophilus, Porphyromonas gingivalis,
Prevotella melaninogenica, S. epidermidis, E. coli, Proteus vul-
garis, P. aeruginosa, Enterococcus aerogenes and Enterobacter
sakazakii.42,54 Quercetin, 3-O-methylquercetin and several
quercetin glycosides,55–59 and also kaempferol and its glyco-
side derivatives,55,57,60 were also reported to have antimicrobial
activity. Other categories of compounds with known anti-
bacterial activity are phenolic acids, such as chlorogenic,
protocatechuic, p-coumaric, caffeic, syringic, p-hydroxybenzoic,
ferulic, vanillic, gentisic and gallic acids,12 their derivatives,42
and flavones (e.g. apigenin and luteolin glycoside
derivatives),12,55,56,61–65 isoflavones,66–69 flavanones,56,70 and
other flavonol glycosides.56,71–74
To the best of the authors’ knowledge, no data are available
on the antibacterial activity of these plants against drug-resist-
ant bacteria in the literature. The obtained results showed that
the antibacterial activity of all of the plant infusions is moder-
ate, especially against Gram-positive bacteria. Moreover, whilst
methicillin-resistant strains usually display resistance to
several drugs, no relevant differences were observed between
methicillin-susceptible and -resistant strains. These data are
also in agreement with earlier studies carried out on other
species belonging to the genus of the studied plants. Aqueous
extracts obtained from Thymus vulgaris showed antibacterial
activity against many ATCC bacterial strains.42,75,76 Moreover,
many solvent fractions of L. guyonianum from Tunisia showed
antibacterial activity against several human pathogenic strains
such as S. aureus, E. feacalis, E. coli, Salmonella typhi and
P. aeruginosa;77 also, the Tunisian L. guyonianum methanolic,
chloroformic and petroleum extracts showed a potent action
against P. aeruginosa and S. aureus with MIC values of 23 and
46 µg mL−1 as the best values, respectively.78 Concerning the
antimicrobial activity of S. satureioides, only the essential oil
was previously studied by the authors,25 and showed strong
potential against ATCC bacterial strains (Bacillus subtilis,
S. aureus, L. monocytogenes, E. faecalis, E. coli, K. pneumoniae,
Proteus mirabilis, P. aeruginosa and Salmonella typhimurium).
According to the results obtained from the HPLC-DAD-ESI/
MSn analysis, the appreciable antibacterial activity of the
extracts against MDR strains could be explained by the wide
spectrum of polyphenols identified in the infusions (previous
section), which act as antimicrobial substances via different
mechanisms of action (MA). In fact, many MA are ascribed to
polyphenols, such as cytoplasmic membrane damage, and
inhibition of nucleic acid, cell wall and cell membrane syn-
thesis.3,55 Moreover, in addition to their direct antibacterial
activity, a growing body of evidence suggests that polyphenols
may interfere with some bacterial virulence factors such as
enzymes, toxins and signal receptors.3,55,56,73
4 Conclusion
Overall, this work focuses on the determination of the pheno-
lic compound profile as well as on the investigation of the anti-
bacterial activity of four medicinal plant species from the
Algerian flora. The identification and quantification of pheno-
lic compounds in T. pallescens, S. satureioides, L. guyonianum
and P. verticillata have been accomplished. The results indicate
Table 4 MIC values (expressed in mg mL−1) of Thymus pallescens, Saccocalyx satureioides, Limoniastrum guyonianum and Ptychotis verticillata
infusions against six Gram-negative and four Gram-positive bacterial strains
Antimicrobial activity MIC values (mg mL−1) Thymus pallescens Saccocalyx satureioides Limoniastrum guyonianum Ptychotis verticillata
Gram-negative bacteria
Escherichia coli 10 5 2.5 20
Escherichia coli ESBL 10 5 2.5 20
Klebsiella pneumoniae 10 10 5 20
Klebsiella pneumoniae ESBL 10 10 5 20
Morganella morganii 20 >20 20 >20
Pseudomonas aeruginosa 20 20 10 >20
Gram-positive bacteria
Enterococcus faecalis 10 10 5 20
Listeria monocytogenes 10 10 5 20
MRSA 5 5 2.5 10
MSSA 5 5 2.5 10
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; MIC, minimal inhibitory concentration;
ESBL, extended-spectrum beta-lactamases.
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that the infusion preparation of T. pallescens and
S. satureioides contained considerable amounts of rosmarinic
acid, lithospermic acid A, luteolin-7-O-glucuronide and api-
genin-6,8-C-dihexoside, while L. guyonianum was rich in myri-
cetin derivatives (glucosides) and P. verticillata was rich in
caffeic acid derivatives particularly 5-O-caffeoylquinic acid. The
findings of this study showed that all four species exhibited a
broad spectrum of antibacterial activity against clinical isolates
(MIC values between 2.5 and 20 mg mL−1), which could be
used as an alternative source of antibiotics. However, pharma-
cological testing is necessary following the isolation of the bio-
active compounds. The infusions of these plants should be
furthermore investigated in vivo to better understand their
efficacy and medicinal properties.
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